0001752724-24-053441.txt : 20240313
0001752724-24-053441.hdr.sgml : 20240313
20240313141230
ACCESSION NUMBER: 0001752724-24-053441
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 3
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240313
DATE AS OF CHANGE: 20240313
EFFECTIVENESS DATE: 20240313
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: VANGUARD VALLEY FORGE FUNDS
CENTRAL INDEX KEY: 0000889519
ORGANIZATION NAME:
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-58431
FILM NUMBER: 24745497
BUSINESS ADDRESS:
STREET 1: P O BOX 2600
STREET 2: V26
CITY: VALLEY FORGE
STATE: PA
ZIP: 19482
BUSINESS PHONE: 6106691000
MAIL ADDRESS:
STREET 1: P.O. BOX 2600
STREET 2: V26
CITY: VALLEY FORGE
STATE: PA
ZIP: 19482
FORMER COMPANY:
FORMER CONFORMED NAME: VANGUARD BALANCED INDEX FUNDS
DATE OF NAME CHANGE: 20070223
FORMER COMPANY:
FORMER CONFORMED NAME: VANGUARD BALANCED INDEX FUND
DATE OF NAME CHANGE: 20011121
FORMER COMPANY:
FORMER CONFORMED NAME: VANGUARD BALANCED INDEX FUND INC
DATE OF NAME CHANGE: 19920715
0000889519
S000002560
VANGUARD BALANCED INDEX FUND
C000007054
INVESTOR SHARES
VBINX
C000007055
ADMIRAL SHARES
VBIAX
C000007056
INSTITUTIONAL SHARES
VBAIX
0000889519
S000019761
Vanguard Managed Allocation Fund
C000055412
Investor Shares
VPGDX
0000889519
S000075775
Vanguard Baillie Gifford Global Positive Impact Stock Fund
C000235057
Investor Shares
VBPIX
0000889519
S000082143
Vanguard Mid-Cap Index Fund
C000245408
Admiral Shares
VIMAX
C000245409
ETF Shares
VO
C000245410
Investor Shares
VIMSX
C000245411
Institutional Shares
VMCIX
N-CEN
1
primary_doc.xml
X0404
N-CEN
LIVE
0000889519
XXXXXXXX
811-58431
true
false
false
N-1A
true
VANGUARD VALLEY FORGE FUNDS
811-58431
0000889519
549300FUTH8HHBEZCJ03
100 Vanguard Boulevard
Malvern
19355
US-PA
US
6106691000
JPMorgan Chase Bank
383 Madison Avenue
New York
10179
212-648-0466
The accounts, books, and other documents required to be maintained by Registrant pursuant to section 31(a) of the Investment Company Act of 1940 and the Rules thereunder.
N
N
N-1A
2
Y
F. Joseph Loughrey
N/A
N
Deanna Mulligan
N/A
N
Peter F. Volanakis
N/A
N
Mark Loughridge
N/A
N
Mortimer J. Buckley
002167630
Y
Andre F. Perold
N/A
N
Emerson U. Fullwood
N/A
N
Sarah Bloom Raskin
N/A
N
Scott C. Malpass
N/A
N
David Thomas
N/A
N
Tara Bunch
N/A
N
Grant Reid
N/A
N
Jacqueline Angell
005606776
100 Vanguard Boulevard
Malvern
19355
XXXXXX
N
N
N
N
N
N
VANGUARD MARKETING CORP.
8-21570
000007452
N/A
Y
N
PRICEWATERHOUSECOOPERS LLP
000000238
5493002GVO7EO8RNNS37
N
N
N
N
N
N
N
VANGUARD BAILLIE GIFFORD GLOBAL POSITIVE IMPACT STOCK FUND
S000075775
549300H2IF21UEITQ770
N
1
0
0
N/A
Y
N
N
N
N/A
N/A
N/A
Rule 32a-4 (17 CFR 270.32a-4)
Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4))
N
N
N
N
Baillie Gifford Overseas Ltd
801-21051
000110296
549300OJXEENXLO4FW52
GB
N
The Vanguard Group, Inc.
084-00772
5493002789CX3L0CJP65
Y
N
N
ITG Analytics Inc
41-2190282
TIN
N
Markit Group Limited
549300HLPTRASHS0E726
GB
N
JPMorgan Chase Bank
7H6GLXDRUGQFU57RNE97
N
Markit North America INC
13-4153988
TIN
N
Refinitiv US LLC
20-4530702
TIN
N
ICE Data Pricing and Reference Data LLC
13-36687789
TIN
N
Bloomberg Finance LP
5493001KJTIIGC8Y1R12
N
N
The Bank of New York Mellon
HPFHU0OQ28E4N0NFVK49
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
The Vanguard Group, Inc.
5493002789CX3L0CJP65
Y
N
N
THE VANGUARD GROUP, INC.
5493002789CX3L0CJP65
Y
N
State Street Bank and Trust Company
571474TGEMMWANRLN572
N
Y
N
Macquarie Capital Securities (Singapore) Pte. Limited
N/A
N/A
5493007PKIT1P8UHLH29
SG
3531.69000000
Merrill Lynch International
N/A
000162416
GGDZP1UYGU9STUHRDP48
GB
5602.79999999
BofA Securities, Inc.
008-69787
000283942
549300HN4UKV1E2R3U73
3018.41000000
J.P. Morgan Securities LLC
008-35008
000000079
ZBUT11V806EZRVTWT807
7977.47000000
Credit Suisse Securities (Europe) Limited
N/A
N/A
DL6FFRRLF74S01HE2M14
GB
2661.90000000
J.P. Morgan Securities PLC
N/A
N/A
K6Q0W1PS1L1O4IQL9C32
GB
2338.02000000
DAIWA SECURITIES CO. LTD.
N/A
N/A
549300D405BPQ5DDVJ61
JP
3559.27000000
Morgan Stanley & Co. LLC
008-15869
000008209
9R7GPTSO7KV3UQJZQ078
2284.07000000
Goldman Sachs International
N/A
N/A
W22LROWP2IHZNBB6K528
GB
3537.22000000
JEFFERIES INTERNATIONAL LIMITED
N/A
N/A
S5THZMDUJCTQZBTRVI98
GB
3639.40000000
56928.88999997
CLSA SINGAPORE PTE LTD
N/A
N/A
2138007HCL683ZPDD829
SG
5595389.42000000
Vanguard Market Liquidity Fund
N/A
N/A
1I6HV0TLSTR3A4XQ6L78
201554522.74000001
207149912.16000001
Y
227885034.83833333
Committed
4300000000.00000000
N
N
N
N
VANGUARD BALANCED INDEX FUND
S000002560
YZYTHJ1EPVBIW2570X33
N
3
0
0
N
N
-0.03177999
-0.24338999
0.76710088
0.76685197
N
N
Y
N
N
The Vanguard Group, Inc.
5493002789CX3L0CJP65
Y
N
Administrative fee
Cash collateral reinvestment fee
68919645.15999999
6509633.95000000
Rule 17a-7 (17 CFR 270.17a-7)
Rule 18f-4(f)(17 CFR 270.18f-4(f))
Rule 32a-4 (17 CFR 270.32a-4)
Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4))
N
N
N
N
The Vanguard Group, Inc.
801-11953
000105958
5493002789CX3L0CJP65
N
The Vanguard Group, Inc.
084-00772
5493002789CX3L0CJP65
Y
N
N
JPMorgan Chase Bank
7H6GLXDRUGQFU57RNE97
N
ICE Data Pricing and Reference Data LLC
13-36687789
TIN
N
Markit North America INC
13-4153988
TIN
N
ITG Analytics Inc
41-2190282
TIN
N
Refinitiv US LLC
20-4530702
TIN
N
Bloomberg Finance LP
5493001KJTIIGC8Y1R12
N
Markit Group Limited
549300HLPTRASHS0E726
GB
N
N
J.P. MORGAN SE - LUXEMBOURG BRANCH
549300ZK53CNGEEI6A29
FR
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
J.P. MORGAN SE - LUXEMBOURG BRANCH
549300ZK53CNGEEI6A29
NL
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
Euroclear
549300OZ46BRLZ8Y6F65
BE
N
Y
Foreign securities depository - rule 17f-7 (17 CFR 270.17f-7)
JPMorgan Chase Bank NA
7H6GLXDRUGQFU57RNE97
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
BNP Paribas Securities Services SCA
R0MUWSFPU8MPRO8K5P83
IT
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
J.P. MORGAN SE - LUXEMBOURG BRANCH
549300ZK53CNGEEI6A29
BE
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
Royal Bank of Canada
ES7IP3U3RHIGC71XBU11
CA
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
Skandinaviska Enskilda Banken AB (publ)
F3JS33DEI6XQ4ZBPTN86
FI
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
JPMorgan Chase Bank NA
7H6GLXDRUGQFU57RNE97
GB
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
N
The Vanguard Group, Inc.
5493002789CX3L0CJP65
Y
N
N
JPMORGAN CHASE BANK, N.A.
7H6GLXDRUGQFU57RNE97
N
Y
THE VANGUARD GROUP, INC.
5493002789CX3L0CJP65
Y
N
N
BofA Securities, Inc.
008-69787
000283942
549300HN4UKV1E2R3U73
60718.72999999
Mizuho Securities USA Inc
008-37710
000019647
5493004GRDTUI7EMIZ82
22591.33000000
CITIGROUP INC.
N/A
N/A
6SHGI4ZSSLCXXQSBB395
168072.11999999
Virtu Americas LLC
008-68193
000149823
549300RA02N3BNSWBV74
10308.49000000
J.P. Morgan Securities LLC
008-35008
000000079
ZBUT11V806EZRVTWT807
51232.58000000
RBC Capital Markets, LLC
008-45411
000031194
549300LCO2FLSSVFFR64
5287.46000000
Barclays Capital Inc.
008-41342
000019714
AC28XWWI3WIBK2824319
55705.36000000
Goldman Sachs & Co. LLC
008-00129
000000361
FOR8UP27PHTHYVLBNG30
30640.72999999
JonesTrading Institutional Services LLC
008-26089
000006888
2138008JJ5PA8H5UIL69
5414.65000000
Morgan Stanley & Co. LLC
008-15869
000008209
9R7GPTSO7KV3UQJZQ078
54554.00000000
485021.58999991
Deutsche Bank Securities Inc.
008-17822
000002525
9J6MBOOO7BECTDTUZW19
606129217.82000012
CITIGROUP INC.
N/A
N/A
6SHGI4ZSSLCXXQSBB395
1234128290.53999949
Goldman Sachs & Co. LLC
008-00129
000000361
FOR8UP27PHTHYVLBNG30
3060682164.90000325
Vanguard Market Liquidity Fund
N/A
N/A
1I6HV0TLSTR3A4XQ6L78
8986603515.23999980
Barclays Capital Inc.
008-41342
000019714
AC28XWWI3WIBK2824319
886377086.92999945
J.P. Morgan Securities LLC
008-35008
000000079
ZBUT11V806EZRVTWT807
1701039274.45999841
Citadel Securities LLC
008-53574
000116797
12UUJYTN7D3SW8KCSG25
533034558.43999988
Morgan Stanley & Co. LLC
008-15869
000008209
9R7GPTSO7KV3UQJZQ078
2945599622.19000067
BofA Securities, Inc.
008-69787
000283942
549300HN4UKV1E2R3U73
1563483320.87000598
Wells Fargo Securities, LLC
008-22947
000007665
VYVVCKR63DVZZN70PB21
1228201197.20000021
26842889827.70000664
N
49435542136.92583333
Committed
4300000000.00000000
N
N
N
N
true
INTERNAL CONTROL RPT
2
valleyforgefunds2.16.txt
Report of Independent Registered Public
Accounting Firm
To the Board of Trustees of Vanguard Valley
Forge Funds and Shareholders of
Vanguard Balanced Index Fund
In planning and performing our audit of the
financial statements of Vanguard Balanced
Index Fund (one of the funds constituting
Vanguard Valley Forge Funds, referred to
hereafter as the "Fund") as of and for the year
ended December 31, 2023, in accordance with
the standards of the Public Company
Accounting Oversight Board (United States)
(PCAOB), we considered the Fund's internal
control over financial reporting, including
controls over safeguarding securities, as a
basis for designing our auditing procedures for
the purpose of expressing our opinion on the
financial statements and to comply with the
requirements of Form N-CEN, but not for the
purpose of expressing an opinion on the
effectiveness of the Fund's internal control over
financial reporting. Accordingly, we do not
express an opinion on the effectiveness of the
Fund's internal control over financial reporting.
The management of the Fund is responsible for
establishing and maintaining effective internal
control over financial reporting. In fulfilling this
responsibility, estimates and judgments by
management are required to assess the
expected benefits and related costs of controls.
A company's internal control over financial
reporting is a process designed to provide
reasonable assurance regarding the reliability
of financial reporting and the preparation of
financial statements for external purposes in
accordance with generally accepted accounting
principles. A company's internal control over
financial reporting includes those policies and
procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately
and fairly reflect the transactions and
dispositions of the assets of the company; (2)
provide reasonable assurance that transactions
are recorded as necessary to permit
preparation of financial statements in
accordance with generally accepted accounting
principles, and that receipts and expenditures
of the company are being made only in
accordance with authorizations of management
and directors of the company; and (3) provide
reasonable assurance regarding prevention or
timely detection of unauthorized acquisition,
use or disposition of a company's assets that
could have a material effect on the financial
statements.
Because of its inherent limitations, internal
control over financial reporting may not prevent
or detect misstatements. Also, projections of
any evaluation of effectiveness to future
periods are subject to the risk that controls may
become inadequate because of changes in
conditions, or that the degree of compliance
with the policies or procedures may deteriorate.
A deficiency in internal control over financial
reporting exists when the design or operation of
a control does not allow management or
employees, in the normal course of performing
their assigned functions, to prevent or detect
misstatements on a timely basis. A material
weakness is a deficiency, or a combination of
deficiencies, in internal control over financial
reporting, such that there is a reasonable
possibility that a material misstatement of the
company's annual or interim financial
statements will not be prevented or detected on
a timely basis.
Our consideration of the Fund's internal control
over financial reporting was for the limited
purpose described in the first paragraph and
would not necessarily disclose all deficiencies
in internal control over financial reporting that
might be material weaknesses under standards
established by the PCAOB. However, we noted
no deficiencies in the Fund's internal control
over financial reporting and its operation,
including controls over safeguarding securities,
that we consider to be a material weakness as
defined above as of December 31, 2023.
This report is intended solely for the information
and use of the Board of Trustees of Vanguard
Valley Forge Funds and the Securities and
Exchange Commission and is not intended to
be and should not be used by anyone other
than these specified parties.
/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
February 16, 2024
INTERNAL CONTROL RPT
3
valleyforgefunds2.15.txt
Report of Independent Registered
Public Accounting Firm
To the Board of Trustees of Vanguard
Valley Forge Funds and Shareholders
of
Vanguard Baillie Gifford Global Positive
Impact Stock Fund
In planning and performing our audit of
the financial statements of Vanguard
Baillie Gifford Global Positive Impact
Stock Fund (one of the funds constituting
Vanguard Valley Forge Funds, referred
to hereafter as the "Fund") as of and for
the year ended December 31, 2023, in
accordance with the standards of the
Public Company Accounting Oversight
Board (United States) (PCAOB), we
considered the Fund's internal control
over financial reporting, including controls
over safeguarding securities, as a basis
for designing our auditing procedures for
the purpose of expressing our opinion on
the financial statements and to comply
with the requirements of Form N-CEN,
but not for the purpose of expressing an
opinion on the effectiveness of the
Fund's internal control over financial
reporting. Accordingly, we do not express
an opinion on the effectiveness of the
Fund's internal control over financial
reporting.
The management of the Fund is
responsible for establishing and
maintaining effective internal control
over financial reporting. In fulfilling this
responsibility, estimates and judgments
by management are required to assess
the expected benefits and related costs
of controls. A company's internal
control over financial reporting is a
process designed to provide
reasonable assurance regarding the
reliability of financial reporting and the
preparation of financial statements for
external purposes in accordance with
generally accepted accounting
principles. A company's internal control
over financial reporting includes those
policies and procedures that (1) pertain
to the maintenance of records that, in
reasonable detail, accurately and fairly
reflect the transactions and dispositions
of the assets of the company; (2)
provide reasonable assurance that
transactions are recorded as necessary
to permit preparation of financial
statements in accordance with
generally accepted accounting
principles, and that receipts and
expenditures of the company are being
made only in accordance with
authorizations of management and
directors of the company; and (3)
provide reasonable assurance
regarding prevention or timely
detection of unauthorized acquisition,
use or disposition of a company's
assets that could have a material effect
on the financial statements.
Because of its inherent limitations,
internal control over financial reporting
may not prevent or detect
misstatements. Also, projections of any
evaluation of effectiveness to future
periods are subject to the risk that
controls may become inadequate
because of changes in conditions, or
that the degree of compliance with the
policies or procedures may deteriorate.
A deficiency in internal control over
financial reporting exists when the
design or operation of a control does
not allow management or employees,
in the normal course of performing their
assigned functions, to prevent or detect
misstatements on a timely basis. A
material weakness is a deficiency, or a
combination of deficiencies, in internal
control over financial reporting, such
that there is a reasonable possibility
that a material misstatement of the
company's annual or interim financial
statements will not be prevented or
detected on a timely basis.
Our consideration of the Fund's internal
control over financial reporting was for
the limited purpose described in the
first paragraph and would not
necessarily disclose all deficiencies in
internal control over financial reporting
that might be material weaknesses
under standards established by the
PCAOB. However, we noted no
deficiencies in the Fund's internal
control over financial reporting and its
operation, including controls over
safeguarding securities, that we
consider to be a material weakness as
defined above as of December 31,
2023.
This report is intended solely for the
information and use of the Board of
Trustees of Vanguard Valley Forge
Funds and the Securities and
Exchange Commission and is not
intended to be and should not be used
by anyone other than these specified
parties.
/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
February 15, 2024